Association of β-Catenin with Fat Accumulation in 3T3-L1 Adipocytes and Human Population
![]() |
Bae, Sung-Min
(Department of Microbiology, Chung-Ang University College of Medicine)
Lee, Hae-Yong (Department of Microbiology, Chung-Ang University College of Medicine) Chae, Soo-Ahn (Department of Pediatrics, Chung-Ang University College of Medicine) Oh, Dong-Jin (Department of Internal Medicine, Chung-Ang University College of Medicine) Park, Suk-Won (Department of Radiation Oncology, Chung-Ang University College of Medicine) Yoon, Yoo-Sik (Department of Microbiology, Chung-Ang University College of Medicine) |
1 | Zuckerman, J. E., T. Hsueh, R. C. Koya, M. E. Davis, and A. Ribas. 2011. siRNA knockdown of ribonucleotide reductase inhibits melanoma cell line proliferation alone or synergistically with temozolomide. J. Invest. Dermatol. 131, 453-460. DOI |
2 | Salpea, K. D., D. R. Gable, J. A. Cooper, J. W. Stephens, S. J. Hurel, H. A. Ireland, M. D. Feher, I. F. Godsland, and S. E. Humphries. 2009. The effect of WNT5B IVS3C>G on the susceptibility to type 2 diabetes in UK Caucasian subjects. Nutr. Metab. Cardiovasc. Dis. 19, 140-145. DOI |
3 | Shao, D. and M. A. Lazar. 1997. Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation. J. Biol. Chem. 272, 21473-21478. DOI |
4 | Van Tienen, F. H., H. Laeremans, C. J. Van der Kallen, and H. J. Smeets. 2009. Wnt5b stimulates adipogenesis by activating PPARgamma, and inhibiting the beta-catenin dependent Wnt signaling pathway together with Wnt5a. Biochem. Biophys. Res. Commun. 387, 207-211. DOI |
5 | Vermeulen, A. 1993. Metabolic effects of obesity in men. Verh. K. Acad. Geneeskd. Belg. 55, 383-393. |
6 | Wall, N. R., and Y. Shi. 2003. Small RNA: can RNA interference be exploited for therapy? Lancet 362, 1401-1403. DOI |
7 | Wang, D. G., J. B. Fan, C. J. Siao, A. Berno, P. Young, R. Sapolsky, G. Ghandour, N. Perkins, E. Winchester, J. Spencer, L. Kruglyak, L. Stein, L. Hsie, T. Topaloglou, E. Hubbell, E. Robinson, M. Mittmann, M. S. Morris, N. Shen, D. Kilburn, J. Rioux, C. Nusbaum, S. Rozen, T. J. Hudson, R. Lipshutz, M. Chee, and E. S. Lander. 1998. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280, 1077-1082. DOI |
8 | Wang, K., W. D. Li, C. K. Zhang, Z. Wang, J. T. Glessner, S. F. Grant, H. Zhao, H. Hakonarson, and R. A. Price. 2011. A genome-wide association study on obesity and obesity-related traits. PLoS One 6, e18939. DOI |
9 | Yamaguchi, Y., M. Moritani, T. Tanahashi, D. Osabe, K. Nomura, Y. Fujita, P. Keshavarz, K. Kunika, N. Nakamura, T. Yoshikawa, E. Ichiishi, H. Shiota, N. Yasui, H. Inoue, and M. Itakura. 2008. Lack of association of genetic variation in chromosome region 15q14-22.1 with type 2 diabetes in a Japanese population. BMC Med. Genet. 9, 22. |
10 | Ma, X., X. Ren, P. Han, S. Hu, J. Wang, and J. Yin. 2010. SiRNA against Fabp5 induces 3T3-L1 cells apoptosis during adipocytic induction. Mol. Biol. Rep. 37, 4003-4011. DOI |
11 | Moldes, M., Y. Zuo, R. F. Morrison, D. Silva, B. H. Park, J. Liu, and S. R. Farmer. 2003. Peroxisome-proliferator- activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. Biochem. J. 376, 607-613. DOI |
12 | Morrison, R. F. and S. R. Farmer. 1999. Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis. J. Biol. Chem. 274, 17088-17097. DOI |
13 | Ntambi, J. M. and K. Young-Cheul. 2000. Adipocyte differentiation and gene expression. J. Nutr. 130, 3122S-3126S. |
14 | Sakurai, K., M. Amarzguioui, D. H. Kim, J. Alluin, B. Heale, M. S. Song, A. Gatignol, M. A. Behlke, and J. J. Rossi. 2011. A role for human Dicer in pre-RISC loading of siRNAs. Nucleic Acids Res. 39, 1510-1525. DOI |
15 | Pereira, D. S., D. M. Garcia, F. M. Narciso, M. L. Santos, J. M. Dias, B. Z, Queiroz, E. R. Souza, O. T. Nobrega, and L. S. Pereira. 2011. Effects of 174 G/C polymorphism in the promoter region of the interleukin-6 gene on plasma IL-6 levels and muscle strength in elderly women. Braz. J. Med. Biol. Res. 44, 123-129. DOI |
16 | Qin, L., Y. Chen, Y. Niu, W. Chen, Q. Wang, S. Xiao, A. Li, Y. Xie, J. Li, X. Zhao, Z. He, and D. Mo. 2010. A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway. BMC Genomics 11, 320. DOI |
17 | Ross, S. E., N. Hemati, K. A. Longo, C. N. Bennett, P. C. Lucas, R. L. Erickson, and O. A. MacDougald. 2000. Inhibition of adipogenesis by Wnt signaling. Science 289, 950-953. DOI ScienceOn |
18 | Dahlman, I. and P. Arner. 2010. Genetics of adipose tissue biology. Prog. Mol. Biol. Transl. Sci. 94, 39-74. DOI |
19 | Gustafson, B., and U. Smith. 2006. Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J. Biol. Chem. 281, 9507-9516. DOI |
20 | Hollister, L. E., J. E. Overall, and H. L. Snow. 1967. Relationship of obesity to serum triglyceride, cholesterol, and uric acid, and to plasma-glucose levels. Am. J. Clin. Nutr. 20, 777-782. |
21 | Huelsken, J. and J. Behrens. 2002. The Wnt signalling pathway. J. Cell Sci. 115, 3977-3978. DOI |
22 | Liu, J. and S. R. Farmer. 2004. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. J. Biol. Chem. 279, 45020-45027. DOI |
23 | Kawai, M., S. Mushiake, K. Bessho, M. Murakami, N. Namba, C. Kokubu, T. Michigami, and K. Ozono. 2007. Wnt/Lrp/beta-catenin signaling suppresses adipogenesis by inhibiting mutual activation of PPARgamma and C/EBPalpha. Biochem. Biophys. Res. Commun. 363, 276-282. DOI |
24 | Lee, H., S. Bae, K. Kim, W. Kim, S. I. Chung, and Y. Yoon. 2010. Beta-Catenin mediates the anti-adipogenic effect of baicalin. Biochem. Biophys. Res. Commun. 398, 741-746. DOI |
25 | Lee, H., R. Kang, S. Bae, and Y. Yoon. 2011. AICAR, an activator of AMPK, inhibits adipogenesis via the WNT/beta-catenin pathway in 3T3-L1 adipocytes. Int. J. Mol. Med. 28, 65-71. |
26 | Livak, K. J. and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408. DOI |
27 | Behari, J., T. H. Yeh, L. Krauland, W. Otruba, B. Cieply, B. Hauth, U. Apte, T. Wu, R. Evans, and S. P. Monga. 2010. Liver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitis. Am. J. Pathol. 176, 744-753. DOI |
28 | Ahmadian, A., B. Gharizadeh, A. C. Gustafsson, F. Sterky, P. Nyren, M. Uhlen, and J. Lundeberg. 2000. Single-nucleotide polymorphism analysis by pyrosequencing. Anal. Biochem. 280, 103-110. DOI |
29 | Al-Shemari, H., Y. Bosse, T. J. Hudson, M. Cabaluna, M. Duval, M. Lemire, S. Vallee-Smedja, S. Frenkiel, and M. Desrosiers. 2008. Influence of leukotriene gene polymorphisms on chronic rhinosinusitis. BMC Med. Genet. 9, 21. |
30 | Albrink, M. J. and J. W. Meigs. 1965. The relationship between serum triglycerides and skinfold thickness in obese subjects. Ann. N. Y. Acad. Sci. 131, 673-683. DOI |
31 | Cadigan, K. M. and Y. I. Liu. 2006. Wnt signaling: complexity at the surface. J. Cell Sci. 119, 395-402. DOI |
32 | Cha, M. H., I. C. Kim, K. S. Kim, B. K. Kang, S. M. Choi, and Y. Yoon. 2007. Association of UCP2 and UCP3 gene polymorphisms with serum high-density lipoprotein cholesterol among Korean women. Metabolism 56, 806-813. DOI |
![]() |